SG Americas Securities’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $272K | Sell |
9,182
-5,095
| -36% | -$151K | ﹤0.01% | 1865 |
|
|
2025
Q1 | $426K | Buy |
14,277
+578
| +4% | +$17.2K | ﹤0.01% | 1704 |
|
|
2024
Q4 | $392K | Sell |
13,699
-4,586
| -25% | -$131K | ﹤0.01% | 1361 |
|
|
2024
Q3 | $707K | Buy |
18,285
+1,470
| +9% | +$56.8K | ﹤0.01% | 1209 |
|
|
2024
Q2 | $541K | Buy |
16,815
+2,785
| +20% | +$89.6K | ﹤0.01% | 1495 |
|
|
2024
Q1 | $545K | Sell |
14,030
-4,214
| -23% | -$164K | ﹤0.01% | 1240 |
|
|
2023
Q4 | $562K | Buy |
18,244
+8,339
| +84% | +$257K | 0.01% | 1263 |
|
|
2023
Q3 | $221K | Buy |
+9,905
| New | +$221K | ﹤0.01% | 2062 |
|
|
2023
Q2 | – | Sell |
-24,472
| Closed | -$587K | – | 2112 |
|
|
2023
Q1 | $587K | Buy |
+24,472
| New | +$587K | 0.01% | 1458 |
|
|
2022
Q3 | – | Sell |
-7,404
| Closed | -$131K | – | 2838 |
|
|
2022
Q2 | $131K | Sell |
7,404
-9,883
| -57% | -$175K | ﹤0.01% | 2692 |
|
|
2022
Q1 | $352K | Sell |
17,287
-15,698
| -48% | -$320K | ﹤0.01% | 1882 |
|
|
2021
Q4 | $616K | Sell |
32,985
-5,756
| -15% | -$107K | ﹤0.01% | 1823 |
|
|
2021
Q3 | $765K | Buy |
+38,741
| New | +$765K | ﹤0.01% | 1958 |
|
|
2021
Q2 | – | Sell |
-9,918
| Closed | -$235K | – | 2559 |
|
|
2021
Q1 | $235K | Buy |
+9,918
| New | +$235K | ﹤0.01% | 2336 |
|
|
2020
Q3 | – | Sell |
-20,494
| Closed | -$359K | – | 2300 |
|
|
2020
Q2 | $359K | Buy |
20,494
+8,448
| +70% | +$148K | ﹤0.01% | 2045 |
|
|
2020
Q1 | $197K | Buy |
12,046
+5,990
| +99% | +$98K | ﹤0.01% | 2110 |
|
|
2019
Q4 | $125K | Buy |
+6,056
| New | +$125K | ﹤0.01% | 2426 |
|
|
2017
Q1 | – | Sell |
-9,891
| Closed | -$154K | – | 2812 |
|
|
2016
Q4 | $154K | Buy |
+9,891
| New | +$154K | ﹤0.01% | 2255 |
|